Next generation sequencing (NGS) is here, and its long-term evolution could spark significant upside for exchange traded funds like the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Long DNA is a new frontier in the genomics space, but it’s applications are critical given the role genetics...